DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional Level

Journal of Virology

Volumn 88, Issue 23, 2014, Pages 13689-13698

  Ko, Chunkyu ^a   Lee, Sooyoung ^a   Windisch, Marc P ^b   Ryu, Wang Shick ^a  

^a Yonsei University   (South Korea)

^b Institute Pasteur Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; DEAD BOX PROTEIN; LENTIVIRUS VECTOR; PROTEIN DDX3; UNCLASSIFIED DRUG; VIRUS DNA; DDX3X PROTEIN, HUMAN;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; DOWN REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; RNA SYNTHESIS; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; GENETIC TRANSCRIPTION; HEPG2 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

HEPATITIS B VIRUS;

DEAD-BOX RNA HELICASES; HEP G2 CELLS; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84911413983     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02035-14     Document Type: Article

References (47)

1. El-Serag HB. 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264-1273 e1. http://dx.doi.org/10.1053/j.gastro.2011.12.061.
2. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. 2009. Control of cccDNA function in hepatitis B virus infection. J. Hepatol. 51:581-592. http://dx.doi.org/10.1016/j.jhep.2009.05.022.
3. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. http://dx.doi.org /10.1038/nature02343.
4. Harris RS, Hultquist JF, Evans DT. 2012. The restriction factors of human immunodeficiency virus. J. Biol. Chem. 287:40875-40883. http: //dx.doi.org/10.1074/jbc.R112.416925.
5. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. 2004. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303:1829. http://dx.doi.org/10.1126/science.1092066.
6. Baumert TF, Rosler C, Malim MH, von Weizsacker F. 2007. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 46:682-689. http://dx.doi.org/10.1002/hep.21733.
7. Rosler C, Kock J, Kann M, Malim MH, Blum HE, Baumert TF, von Weizsacker F. 2005. APOBEC-mediated interference with hepadnavirus production. Hepatology 42:301-309. http://dx.doi.org/10.1002/hep.20801.
8. Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, Candinas D, Sommer P, Wain-Hobson S, Vartanian JP, Greeve J. 2006. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43:1364-1374. http://dx.doi.org/10.1002/hep.21187.
9. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP. 2005. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:8321-8326. http://dx.doi.org/10.1073/pnas.0408223102.
10. Nguyen DH, Gummuluru S, Hu J. 2007. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J. Virol. 81:4465-4472. http://dx.doi.org/10.1128/JVI.02510-06.
11. Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T, Remouchamps C, Chou WM, Thasler WE, Huser N, Durantel D, Liang TJ, Munk C, Heim MH, Browning JL, Dejardin E, Dandri M, Schindler M, Heikenwalder M, Protzer U. 2014. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343:1221-1228. http://dx.doi.org/10.1126/science.1243462.
12. Rocak S, Linder P. 2004. DEAD-box proteins: the driving forces behind RNA metabolism. Nat. Rev. Mol. Cell Biol. 5:232-241. http://dx.doi.org /10.1038/nrm1335.
13. Schroder M. 2010. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem. Pharmacol. 79:297-306. http://dx.doi.org/10.1016/j.bcp.2009.08.032.
14. Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YH. 2006. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res. 66:6579-6588. http://dx.doi.org/10.1158/0008-5472.CAN-05-2415.
15. Botlagunta M, Vesuna F, Mironchik Y, Raman A, Lisok A, Winnard P, Jr, Mukadam S, Van Diest P, Chen JH, Farabaugh P, Patel AH, Raman V. 2008. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 27:3912-3922. http://dx.doi.org/10.1038/onc.2008.33.
16. Soulat D, Burckstummer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. 2008. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27:2135-2146. http://dx.doi.org/10.1038/emboj.2008.126.
17. Schroder M, Baran M, Bowie AG. 2008. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 27:2147-2157. http://dx.doi.org/10.1038/emboj.2008.143.
18. Gu L, Fullam A, Brennan R, Schroder M. 2013. Human DEAD box helicase 3 couples IkappaB kinase epsilon to interferon regulatory factor 3 activation. Mol. Cell. Biol. 33:2004-2015. http://dx.doi.org/10.1128/MCB.01603-12.
19. Li C, Ge LL, Li PP, Wang Y, Dai JJ, Sun MX, Huang L, Shen ZQ, Hu XC, Ishag H, Mao X. 2014. Cellular DDX3 regulates Japanese encephalitis virus replication by interacting with viral un-translated regions. Virology 449:70-81. http://dx.doi.org/10.1016/j.virol.2013.11.008.
20. Ariumi Y, Kuroki M, Abe K, Dansako H, Ikeda M, Wakita T, Kato N. 2007. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 81:13922-13926. http://dx.doi.org/10.1128/JVI.01517-07.
21. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT. 2004. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119:381-392. http://dx.doi.org/10.1016/j.cell.2004.09.029.
22. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, Chien M, Weir DB, Russo JJ, Ju J, Brownstein MJ, Sheridan R, Sander C, Zavolan M, Tuschl T, Rice CM. 2007. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. U. S. A. 104:12884-12889. http://dx.doi.org/10.1073/pnas.0704894104.
23. Soto-Rifo R, Rubilar PS, Ohlmann T. 2013. The DEAD-box helicase DDX3 substitutes for the cap-binding protein eIF4E to promote compartmentalized translation initiation of the HIV-1 genomic RNA. Nucleic Acids Res. 41:6286-6299. http://dx.doi.org/10.1093/nar/gkt306.
24. Wang H, Kim S, Ryu WS. 2009. DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J. Virol. 83:5815-5824. http://dx.doi.org/10.1128/JVI.00011-09.
25. Cha MY, Ryu DK, Jung HS, Chang HE, Ryu WS. 2009. Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J. Gen. Virol. 90:978-986. http://dx.doi.org /10.1099/vir.0.009928-0.
26. Guo H, Jiang D, Zhou T, Cuconati A, Block TM, Guo JT. 2007. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis Bvirus: an intermediate of covalently closed circularDNAformation. J. Virol. 81:12472-12484. http://dx.doi.org/10.1128/JVI.01123-07.
27. Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S. 2014. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. J. Hepatol. 60:723-731. http://dx.doi.org /10.1016/j.jhep.2013.11.022.
28. Watashi K, Liang G, Iwamoto M, Marusawa H, Uchida N, Daito T, Kitamura K, Muramatsu M, Ohashi H, Kiyohara T, Suzuki R, Li J, Tong S, Tanaka Y, Murata K, Aizaki H, Wakita T. 2013. Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID). J. Biol. Chem. 288:31715-31727. http://dx.doi.org/10.1074/jbc.M113.501122.
29. Ko C, Shin YC, Park WJ, Kim S, Kim J, Ryu WS. 2014. Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis. J. Virol. 88:154-163. http://dx.doi.org/10.1128/JVI.01916-13.
30. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049. http://dx.doi.org/10.7554/eLife.00049.
31. Cai D, Nie H, Yan R, Guo JT, Block TM, Guo H. 2013. A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures. Methods Mol. Biol. 1030:151-161. http://dx.doi.org/10.1007/978-1-62703-484-5_13.
32. Ryu DK, Kim S, Ryu WS. 2008. Hepatitis B virus polymerase suppresses translation of pregenomic RNA via a mechanism involving its interaction with 5= stem-loop structure. Virology 373:112-123. http://dx.doi.org/10.1016/j.virol.2007.11.010.
33. Chomczynski P, Sacchi N. 2006. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat. Protoc. 1:581-585. http://dx.doi.org/10.1038/nprot.2006.83.
34. Guo H, Jiang D, Ma D, Chang J, Dougherty AM, Cuconati A, Block TM, Guo JT. 2009. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. J. Virol. 83:847-858. http://dx.doi.org/10.1128 /JVI.02008-08.
35. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, Stindt J, Koniger C, Nassal M, Kubitz R, Sultmann H, Urban S. 2014. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146:1070- 1083. http://dx.doi.org/10.1053/j.gastro.2013.12.024.
36. Cai D, Mills C, Yu W, Yan R, Aldrich CE, Saputelli JR, Mason WS, Xu X, Guo JT, Block TM, Cuconati A, Guo H. 2012. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation. Antimicrob. Agents Chemother. 56:4277-4288. http://dx.doi.org/10.1128/AAC.00473-12.
37. Fuller-Pace FV. 2013. The DEAD box proteins DDX5 (p68) and DDX17 (p72): multi-tasking transcriptional regulators. Biochim. Biophys. Acta 1829:756-763. http://dx.doi.org/10.1016/j.bbagrm.2013.03.004.
38. Owsianka AM, Patel AH. 1999. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257:330-340. http://dx.doi.org/10.1006/viro.1999.9659.
39. Li J, Lin S, Chen Q, Peng L, Zhai J, Liu Y, Yuan Z. 2010. Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs. J. Virol. 84: 6387-6399. http://dx.doi.org/10.1128/JVI.00236-10.
40. Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block TM, Guo JT, Guo H. 2013. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 9:e1003494. http://dx.doi.org/10.1371/journal.ppat.1003494.
41. Sells MA, Chen ML, Acs G. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U. S. A. 84:1005-1009. http://dx.doi.org/10.1073/pnas.84.4.1005.
42. Gao W, Hu J. 2007. Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J. Virol. 81:6164-6174. http://dx.doi.org/10.1128/JVI.02721-06.
43. Jones SA, Boregowda R, Spratt TE, Hu J. 2012. In vitro epsilon RNAdependent protein priming activity of human hepatitis B virus polymerase. J. Virol. 86:5134-5150. http://dx.doi.org/10.1128/JVI.07137-11.
44. Bouchard MJ, Schneider RJ. 2004. The enigmatic X gene of hepatitis B virus. J. Virol. 78:12725-12734. http://dx.doi.org/10.1128/JVI.78.23.12725-12734.2004.
45. Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, Raimondo G, Levrero M. 2009. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc. Natl. Acad. Sci. U. S. A. 106:19975-19979. http://dx.doi.org/10.1073 /pnas.0908365106.
46. Wang H, Ryu WS. 2010. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog. 6:e1000986. http://dx.doi.org/10.1371 /journal.ppat.1000986.
47. Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z. 2010. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKK and DDX3. J. Gen. Virol. 91(8):2080-2090. http://dx.doi.org/10.1099/vir.0.020552-0.